Example of Journal of Psychopharmacology format
Recent searches

Example of Journal of Psychopharmacology format Example of Journal of Psychopharmacology format Example of Journal of Psychopharmacology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Journal of Psychopharmacology format Example of Journal of Psychopharmacology format Example of Journal of Psychopharmacology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Journal of Psychopharmacology — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Psychiatry and Mental Health #75 of 502 down down by 34 ranks
Pharmacology (medical) #48 of 246 down down by 27 ranks
Pharmacology #77 of 297 down down by 32 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 563 Published Papers | 3423 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 02/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Bentham Science

Quality:  
High
CiteRatio: 10.5
SJR: 1.955
SNIP: 1.851
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 6.2
SJR: 1.783
SNIP: 1.498
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 6.3
SJR: 1.603
SNIP: 1.26
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

3.121

26% from 2018

Impact factor for Journal of Psychopharmacology from 2016 - 2019
Year Value
2019 3.121
2018 4.221
2017 4.738
2016 4.179
graph view Graph view
table view Table view

6.1

6% from 2019

CiteRatio for Journal of Psychopharmacology from 2016 - 2020
Year Value
2020 6.1
2019 6.5
2018 7.8
2017 7.2
2016 7.6
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 26% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has decreased by 6% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.333

1% from 2019

SJR for Journal of Psychopharmacology from 2016 - 2020
Year Value
2020 1.333
2019 1.342
2018 1.672
2017 1.939
2016 2.095
graph view Graph view
table view Table view

1.061

6% from 2019

SNIP for Journal of Psychopharmacology from 2016 - 2020
Year Value
2020 1.061
2019 1.127
2018 1.34
2017 1.299
2016 1.283
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 1% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 6% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Journal of Psychopharmacology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Journal of Psychopharmacology

The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians o...... Read More

Psychiatry and Mental health

Pharmacology (medical)

Medicine

i
Last updated on
02 Jul 2020
i
ISSN
0269-8811
i
Impact Factor
High - 1.039
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 1982; 25(7): 4515–4532. URL 10.1103/PhysRevB.25.4515.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1177/0269881116675513
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Abstract:

Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. Th... Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. Th... read more read less

Topics:

Anxiety (59%)59% related to the paper, Psilocybin (53%)53% related to the paper, Depression (differential diagnoses) (51%)51% related to the paper
View PDF
1,016 Citations
open accessOpen access Journal Article DOI: 10.1177/0269881116636545
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

Abstract:

The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also... The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change. read more read less

Topics:

Evidence-based medicine (59%)59% related to the paper, Evidence-based practice (56%)56% related to the paper, Cognitive behavioral therapy (53%)53% related to the paper
View PDF
989 Citations
Journal Article DOI: 10.1177/026988119100500414
5-HT and mechanisms of defence.

Abstract:

are concerned with adaptive responses to aversive events. Aversive stimuli can be defined as stimuli which motivate avoidance behaviour. This definition encompasses negative incentives and reinforcers and much of what passes under vaguer terms such as ’punishers’ and ’stresses’. Aversive stimuli can be considered in three gro... are concerned with adaptive responses to aversive events. Aversive stimuli can be defined as stimuli which motivate avoidance behaviour. This definition encompasses negative incentives and reinforcers and much of what passes under vaguer terms such as ’punishers’ and ’stresses’. Aversive stimuli can be considered in three groups and we suggest they bring different anatomical structures and 5-HT systems into play. Dysfunction in these central mechanisms of aversion results in different groups of psychological symptoms. The three forms of aversion are summarized below and they form the basis of this article. read more read less
921 Citations
open accessOpen access Journal Article DOI: 10.1177/0269881116675512
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Abstract:

Background:Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a... Background:Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a... read more read less

Topics:

Anxiety (58%)58% related to the paper, Randomized controlled trial (54%)54% related to the paper, Depression (differential diagnoses) (53%)53% related to the paper
View PDF
823 Citations
open accessOpen access Journal Article DOI: 10.1177/1359786810385490
Suicide and schizophrenia: a systematic review of rates and risk factors
Kahyee Hor1, Matthew Taylor1

Abstract:

Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all original studies concerning suicide in schizophrenia published since 2004. We found 51 data-containing studies (from 1281 studies screened) that met our inclusion criteria... Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all original studies concerning suicide in schizophrenia published since 2004. We found 51 data-containing studies (from 1281 studies screened) that met our inclusion criteria, and ranked these by standardized quality criteria. Estimates of rates of suicide and risk factors associated with later suicide were identified, and the risk factors were grouped according to type and strength of association with suicide. Consensus on the lifetime risk of suicide was a rate of approximately 5%. Risk factors with a strong association with later suicide included being young, male, and with a high level of education. Illness-related risk factors were important predictors, with number of prior suicide attempts, depressive symptoms, active hallucinations and delusions, and the presence of insight all having a strong evidential basis. A family history of suicide, and comorbid substance misuse were also positively associated with later suicide. The only consistent protective factor for suicide was delivery of and adherence to effective treatment. Prevention of suicide in schizophrenia will rely on identifying those individuals at risk, and treating comorbid depression and substance misuse, as well as providing best available treatment for psychotic symptoms. read more read less

Topics:

Suicide prevention (67%)67% related to the paper, Risk factor (57%)57% related to the paper, Risk assessment (56%)56% related to the paper, Protective factor (52%)52% related to the paper, Poison control (52%)52% related to the paper
View PDF
694 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Journal of Psychopharmacology.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Journal of Psychopharmacology format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Journal of Psychopharmacology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Journal of Psychopharmacology guidelines and auto format it.

2. Do you follow the Journal of Psychopharmacology guidelines?

Yes, the template is compliant with the Journal of Psychopharmacology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Journal of Psychopharmacology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Journal of Psychopharmacology citation style.

4. Can I use the Journal of Psychopharmacology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Journal of Psychopharmacology.

5. Can I use a manuscript in Journal of Psychopharmacology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Journal of Psychopharmacology that you can download at the end.

6. How long does it usually take you to format my papers in Journal of Psychopharmacology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Journal of Psychopharmacology.

7. Where can I find the template for the Journal of Psychopharmacology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Psychopharmacology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Journal of Psychopharmacology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Journal of Psychopharmacology an online tool or is there a desktop version?

SciSpace's Journal of Psychopharmacology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Journal of Psychopharmacology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Journal of Psychopharmacology?”

11. What is the output that I would get after using Journal of Psychopharmacology?

After writing your paper autoformatting in Journal of Psychopharmacology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Journal of Psychopharmacology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Journal of Psychopharmacology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Journal of Psychopharmacology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Journal of Psychopharmacology?

The 5 most common citation types in order of usage for Journal of Psychopharmacology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Journal of Psychopharmacology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Psychopharmacology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Journal of Psychopharmacology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Journal of Psychopharmacology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Journal of Psychopharmacology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template